Gelonghui May 8 丨 Health Yuan (600380)(600380freeplaynodeposit.SH) expressed on the interactive platformfreeplaynodepositThe company uses the Health Yuan Research Institute as a research and development platform for synthetic biology, mainly including the transformation and design of Escherichia coli, filamentous fungi, Saccharomyces cerevisiae and Streptomyces. The company is building an autonomous and controllable knowledge base, using the AlphaFold 2 algorithm to predict the protein structure of key enzymes on the CPC metabolic pathway, and using artificial intelligence methods for natural product biosynthetic pathways to predict.freeplaynodepositKey genes for aromatic amino acid metabolic by-products were identified. As of the end of 2023, the Health Yuan Research Institute has applied for a total of 14 national invention patents (4 authorized invention patents), applied for 8 utility model patents (4 authorized utility model patents), obtained 1 software copyright, and published high-level academic 2 papers.